Balance Sheet for Phio Pharmaceuticals Corp. (PHIO)

$ 2.56   0.09 (+3.64%) Volume: 451.34k 4:00 PM EDT 5-Jun-2020
After Hours:  $ 2.56 0.00 (0.00%) Volume: 687 5:53 PM EDT 5-Jun-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 6,934 14,879 3,581 12,906 5,117
Restrictable Cash 50 50 50 50 50
Marketable Securities - - - - 5,500
Accounts Receivable - - - - -
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - - - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 316 221 201 150 311
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 7,300 15,150 3,832 13,106 10,978
Land and Improvements - - - - -
Buildings and Improvement - - - - -
Machinery, Furniture and Equipment - - - - -
Construction in Progress - - - - -
Fixed Assets, Other 1,769 1,153 1,148 945 941
Fixed Assets, Total 1,769 1,153 1,148 945 941
Gross Fixed Assets 1,769 1,153 1,148 945 941
Accumulated Depreciation (1,048) (981) (900) (831) (778)
Net Fixed Assets 721 172 248 114 163
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 18 - 18 27 18
Total Non-Current Assets 739 172 266 291 181
Total Assets 8,039 15,322 4,098 13,397 11,159
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 809 550 511 917 1,163
Short Term Debt 107 - - - -
Notes Payable - - - - -
Accrued Expenses 413 757 1,019 880 381
Accrued Liabilities 413 757 1,019 880 381
Deferred Revenues - - - - -
Current Deferred Income Taxes - - (1,621) - -
Other Current Liabilities 551 437 735 745 725
Total Current Liabilities 1,880 1,744 2,265 2,542 2,269
Long Term Debt N/A N/A - - -
Deferred Income Tax - - - - -
Other Non-Current Liabilities - - - (3,525) (3,106)
Minority Interest - - - - -
Capital Lease Obligations 411 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - 3,085
Total Non-Current Liabilities 411 - - - (21)
Total Liabilities 2,291 1,744 2,265 2,542 2,248
Preferred Shareholder's Equity - - - 3,525 21
Common Shareholder's Equity 5,748 13,578 1,833 7,330 8,890
Common Par 1 - - - 1
Additional Paid in Capital 100,566 99,489 80,384 73,429 65,994
Cumulative Translation Adjustments - - - - -
Retained Earnings (94,819) (85,911) (78,551) (66,099) (57,105)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization 5,748 13,578 1,833 10,855 8,911
Total Equity 5,748 13,578 1,833 10,855 8,911
Total Liabilities & Shareholder's Equity 8,039 15,322 4,098 13,397 11,159
Cash Flow (8,908) (7,360) (12,452) (11,069) (10,432)
Working Capital 5,420 13,406 1,567 10,564 8,709
Free Cash Flow (8,717) (7,525) (9,717) (7,764) (7,374)
Invested Capital 5,748 13,578 1,833 10,855 8,890
Shares Outstanding - Common Class Only 669 343 2,430 1,300 653
Preferred Shares Outstanding - - - - 0
Total Ordinary Shares 669 343 2,430 1,300 653
Total Common Shares Outstanding 669 343 2,430 1,300 653
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 460 128 2,258 675 497
Diluted Weighted Shares Outstanding 460 128 2,258 675 497